首页> Cancers> A Novel Nomogram for Estimating a High-Risk Result in the EndoPredict<sup>®</sup> Test for Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Carcinoma.

A Novel Nomogram for Estimating a High-Risk Result in the EndoPredict<sup>®</sup> Test for Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Carcinoma.

导出 OA

翻译打印收藏纠错

第一作者： Víctor,Macarrón

第一单位： Department of Pathology, Hospital Universitario La Paz, 28046 Madrid, Spain.

作者： Víctor,Macarrón ^[1] ; Itsaso,Losantos-García ^[2] ; Alberto,Peláez-García ^[3] ; Laura,Yébenes ^[4] ; Alberto,Berjón ^[4] ; Laura,Frías ^[5] ; Covadonga,Martí ^[5] ; Pilar,Zamora ^[6] ; José Ignacio,Sánchez-Méndez ^[7] ; David,Hardisson ^[8]

作者单位： Department of Pathology, Hospital Universitario La Paz, 28046 Madrid, Spain. ^[1] Biostatistics Department, Hospital Universitario La Paz, 28046 Madrid, Spain. ^[2] Molecular Pathology and Therapeutic Targets Group, La Paz University Hospital (IdiPAZ), 28046 Madrid, Spain. ^[3] Department of Pathology, Hospital Universitario La Paz, 28046 Madrid, Spain.;Molecular Pathology and Therapeutic Targets Group, La Paz University Hospital (IdiPAZ), 28046 Madrid, Spain. ^[4] Breast Unit, Department of Gynecology and Obstetrics, Hospital Universitario La Paz, 28046 Madrid, Spain. ^[5] Department of Medical Oncology, Hospital Universitario La Paz, 28046 Madrid, Spain. ^[6] Molecular Pathology and Therapeutic Targets Group, La Paz University Hospital (IdiPAZ), 28046 Madrid, Spain.;Breast Unit, Department of Gynecology and Obstetrics, Hospital Universitario La Paz, 28046 Madrid, Spain.;Faculty of Medicine, Universidad Autónoma de Madrid, 28029 Madrid, Spain. ^[7] Department of Pathology, Hospital Universitario La Paz, 28046 Madrid, Spain.;Molecular Pathology and Therapeutic Targets Group, La Paz University Hospital (IdiPAZ), 28046 Madrid, Spain.;Faculty of Medicine, Universidad Autónoma de Madrid, 28029 Madrid, Spain.;Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain. ^[8]

关键词 EndoPredict breast cancer nomogram prognosis recurrence

DOI 10.3390/cancers17020273

PMID 39858055

发布时间 2025-01-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交